XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash $ 4,325 $ 1,810
Other receivables 184 121
Prepaid expenses 841 697
Inventory 80
Total current assets 5,430 2,628
Non current assets    
Prepaid expenses 669 1,657
Equipment, net 235 136
Intangible assets, net 898 180
Goodwill 5,175
Total non current assets 6,977 1,973
TOTAL ASSETS 12,407 4,601
Current liabilities    
Trade payables 1,345 1,816
Accrued liabilities 658 1,626
Deferred revenue 238 13
Convertible promissory note, net of unamortized discount 694
Deemed dividend liability
Contingent consideration payable 478
Derivative liability 0 827
Total current liabilities 2,719 4,976
Non current liabilities    
Deferred revenue 31
TOTAL LIABILITIES 2,750 4,976
COMMITMENTS AND CONTINGENCIES (Note 12)
SHAREHOLDERS’ EQUITY (DEFICIT)    
Preferred shares, $0.0001 par value: 1,000,000 shares authorized; nil issued and outstanding at September 30, 2025 and December 31, 2024
Common shares, $0.0001 par value: 100,000,000 shares authorized; 13,477,012 and 8,122,060 issued and outstanding at September 30, 2025 and December 31, 2024, respectively 1 1
Additional paid-in capital 118,552 86,708
Accumulated deficit (108,896) (87,084)
TOTAL SHAREHOLDERS’ EQUITY (DEFICIT) 9,657 (375)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 12,407 $ 4,601